PureTech Health Plc(OTC) PRTC

Current Price$0.00

Market CapN/A

Since IPO (2020)-56%

5 YearN/A

1 Year-100%

1 Month-100%

PureTech Health Plc last closing stock price
Metric	Price	Date
Last close	USD 0.00	2006-12-26

PureTech Health Plc stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-99.99%	USD 1.04	2005-10-03
1 month	-99.99%	USD 1.04	2005-10-03
3 month	-99.99%	USD 1.04	2005-10-03
Year to date	-99.99%	USD 1.04	2005-10-03
1 year	-99.99%	USD 1.04	2005-10-03
Since inception	-55.84%	USD 38.50	2020-11-16

PureTech Health Plc Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$8.96M

Net Income (TTM)

-$55.98M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Apr 29, 2026

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Apr 29, 2026

PRTC News

PureTech Health Cash Runway Extended

Motley Fool Markets TeamSep 2, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PureTech Health Plc

PureTech Health plc is a biotechnology company focused on developing differentiated medicines for serious diseases, including inflammatory, fibrotic, and immunological conditions. The company operates through various segments, including Internal, Controlled Founded Entities, and Non-Controlled Founded Entities, aiming to address unmet medical needs across multiple therapeutic areas.

Products and Services

Innovative therapies targeting inflammatory and fibrotic diseases
Development of treatments for intractable cancers and neurological disorders
Research initiatives in gastrointestinal and lymphatic diseases

Growth Outlook

Strong pipeline with multiple candidates in clinical development stages
Recent partnerships enhancing research capabilities and market reach
Focus on expanding therapeutic areas to capture broader market opportunities

Financial Highlights

Recent quarterly revenue of $2.8 million, showing growth potential
Cash and short-term investments totaling $278.9 million, providing operational flexibility
Current ratio of 6.59, indicating strong liquidity position

PureTech Health plc is positioned in the biotechnology sector, focusing on innovative solutions for complex health challenges. The company’s diverse product pipeline and strategic partnerships are designed to enhance its market presence and drive future growth. Recent financial data reflects a solid liquidity position, which is crucial for funding ongoing research and development efforts. With a commitment to addressing significant unmet medical needs, PureTech Health presents an intriguing opportunity for investors interested in the biotechnology landscape.

AI Generated • Jul 24, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Boston, MA 02210, US

PRTC Financials

Key Financial Metrics (TTM)

Gross Margin

-471.15%

Operating Margin

-2115.41%

Net Income Margin

-2355.50%

Return on Equity

-31.83%

Return on Capital

-29.71%

Return on Assets

-20.48%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$17.59M

Operating Income

-$234.43M

EBITDA

-$57.61M

Operating Cash Flow

-$219.18M

Capital Expenditure

-$16.98K

Free Cash Flow

-$219.20M

Cash & ST Invst.

$278.90M

Total Debt

$19.59M

PureTech Health Plc Performance Analysis

PureTech Health Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-06-30	61.3%
Q4	2024-12-31	1298.3%
Q2	2025-06-30	-54.0%
Q4	2025-12-31	51.1%

PureTech Health Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-06-30	-99.5%
Q4	2024-12-31	333.3%
Q2	2025-06-30	-154.3%
Q4	2025-12-31	-1315.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$2.80M

+1466.6%

Gross Profit

$1.15M

+168.4%

Gross Margin

41.03%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$64.89M

-60.7%

EBITDA

-$48.75M

-336.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

$278.90M

-14.7%

Total Debt

$19.59M

-22.7%

Accounts Receivable

$8.13M

+242.2%

Inventory

$0.00

N/A

Long Term Debt

$11.09M

-39.2%

Short Term Debt

$8.50M

+19.8%

Return on Assets

-20.48%

N/A

Return on Invested Capital

-20.13%

N/A

Free Cash Flow

-$38.48M

+4.1%

Operating Cash Flow

-$38.47M

+3.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AUTLAutolus Therapeutics plc

AUTLAutolus Therapeutics plc$1.52+5.56%

NGNENeurogene Inc.

NGNENeurogene Inc.$35.57-1.50%

SLDBSolid Biosciences Inc.

SLDBSolid Biosciences Inc.$7.98-1.48%

QSIQuantum-Si incorporated

QSIQuantum-Si incorporated$0.79-1.25%

BNTCBenitec Biopharma Inc.

BNTCBenitec Biopharma Inc.$11.44+0.00%

ADCTADC Therapeutics S.A.

ADCTADC Therapeutics S.A.$1.22-1.61%

ALMSAlumis Inc.

ALMSAlumis Inc.$28.30-1.77%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.76-0.29%

INTCIntel

INTCIntel$100.23-0.02%

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares$36.49+0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.27+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$66.30-0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$118.24+0.03%

GOOGLAlphabet

GOOGLAlphabet$317.69-0.07%

Questions About PRTC

What is the current price of PureTech Health Plc?

PureTech Health Plc is trading at N/A per share.

What is the 52-week range for PureTech Health Plc?

Over the past 52 weeks, PureTech Health Plc has traded between N/A and N/A.

How much debt does PureTech Health Plc have?

PureTech Health Plc total debt is unavailable.

How much cash does PureTech Health Plc have on hand?

PureTech Health Plc does not have cash on hand data available.

What is PureTech Health Plc’s dividend yield?

PureTech Health Plc does not currently have a dividend yield.

PureTech Health Plc(OTC) PRTC

PureTech Health Plc Financials at a Glance

PRTC News

PureTech Health Cash Runway Extended

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PureTech Health Plc

PRTC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PureTech Health Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PRTC

What is the current price of PureTech Health Plc?

What is the 52-week range for PureTech Health Plc?

How much debt does PureTech Health Plc have?

How much cash does PureTech Health Plc have on hand?

What is PureTech Health Plc’s dividend yield?

Premium Investing Services